solution by MARKET
Pharmaceutical Production Lines & Turnkey Factory Solutions for Uzbekistan
From IV solution lines and OSD plants to injectable filling systems and cleanroom engineering — GMP-compliant manufacturing infrastructure built for Central Asia’s largest and fastest-growing pharmaceutical market.
A Clear View of the Local Market Landscape
The volume of Uzbekistan’s pharma market ($2.136 billion in MAT/08/2025) has surpassed that of Kazakhstan, reflecting Uzbekistan’s larger population and growing demand — strengthening the country’s position as the largest pharmaceutical market in Central Asia. In just January–August 2025, over $290 million was invested in the industry, of which $262.7 million were foreign investments. However, although the share of local products in this market is 40–45 percent in physical volume, in monetary terms it does not exceed 20 percent, underscoring the enormous opportunity for manufacturers investing in new GMP production capacity. Up to 80% of the annual demand for pharmaceutical products in the next five years is targeted to be provided by local production, creating massive demand for production lines, cleanroom systems, and complete factory infrastructure.
Demand Trends Within the Country
-
Pharmaceutical Manufacturing Localization
The government is encouraging localization of production, offering incentives (such as tax and customs benefits in pharmaceutical free economic zones) and reserving 20% of state procurements for domestic companies’ products. This drives urgent demand for new factory builds. -
Injectable & IV Solution Production
With a population of ~35 million and rising healthcare spending, Uzbekistan critically needs locally produced IV fluids, injectable antibiotics, insulin, and vaccines to reduce its heavy import dependence. -
OSD & Generic Drug Manufacturing
Rx-drugs prevail in the structure of retail sales, and affordable generic tablet and capsule production is the highest-priority investment to serve domestic demand and neighboring CIS export markets. -
GMP Compliance & Regulatory Upgrading
From January 1, 2026, all pharmaceutical manufacturers will be required to obtain a national GMP certificate to register their products in Uzbekistan — without proof of compliance, registering new drugs or renewing certificates will be impossible.
Local Experience, Reliable Execution
-
Proven Central Asia delivery track record — 2,500+ production lines deployed in 60+ countries, with extensive project experience across CIS and Central Asian pharmaceutical markets.
-
GMP alignment for Uzbekistan’s new requirements — All systems pre-engineered to meet EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP standards — positioning clients ahead of Uzbekistan’s mandatory GMP certification requirement effective January 2026.
-
Full turnkey EPC capability — From consulting and process design through equipment manufacturing, cleanroom construction, utility installation, IQ/OQ/PQ validation, technology transfer, and operator training — one partner, one contract.
-
Customized for Uzbekistan’s strategic priorities — Solutions tailored for import substitution, Tashkent Pharma Park and FEZ investments, and regional export ambitions targeting EAEU, Southeast Asia, and Middle East markets.
Selected Products for This Market
-
30ml Glass Bottle Syrup Filling and Capping Machine for Pharmaceutical
Introduction IVEN Syrup filling and capping machine 1.IVEN Syrup filling and capping machine is made up of CLQ ultrasonic washing ,RSM drying &sterilizing machine,DGZ filling & capping machine 2.IVEN Syrup filling and capping machine can complete following functions of ultrasonic washing ,flushing, (air charging, drying& sterilizing optional) ,filling and capping /screwing. 3.IVEN Syrup filling and… -
IV Infusion Glass Bottle Turnkey Project
Product Description: IVEN Pharmatech is the pioneer supplier of turnkey plants that provides integrated engineering solution for worldwide pharmaceutical factory such as IV solution, vaccine, oncology etc., in compliance with EU GMP, US FDA cGMP, PICS, and WHO GMP. We provide the most reasonable project design, the high quality equipment and the customized service to… -
Bioreactor
Introduction IVEN provides professional services in engineering design, processing and manufacturing, project management, verification, and after-sales service. It provides biopharmaceutical companies such as vaccines, monoclonal antibody drugs, recombinant protein drugs, and other biopharmaceutical companies with individualization from laboratory, pilot test to production scale. A full range of mammalian cell culture bioreactors and innovative overall engineering solutions. The… -
High Speed Tablet Press Machine
Introduction This high speed tablet press machine is controlled by PLC and touch screen man-machine interface. The pressure of the punch is detected by an imported pressure sensor to achieve real-time pressure detection and analysis. Automatically adjust the powder filling depth of the tablet press to realize automatic control of tablet production. At the same…
Meeting Local Standards with Reliable Delivery
Compliance & Certification
Logistics & Delivery
Success Snapshot
-
Pharmaceutical Manufacturer
Delivered an integrated OSD production plant including tablet and capsule lines, purified water system, cleanroom, and blister packaging within a pharmaceutical free economic zone. The facility obtained national GMP certification and achieved annual output of 400 million tablets and 100 million capsules, enabling the client to serve the domestic market and export to three neighboring CIS countries.
-
Healthcare Investment Group
Supplied a PP bottle IV solution production line with pharmaceutical water system, cleanroom, and automated packaging. The project was completed in 14 months and passed GMP inspection, producing 15 million bottles of IV solution annually and contributing directly to the national localization program.
Trusted by Local Customers
-
“IVEN delivered our complete OSD factory — from equipment and cleanroom to water system and packaging — under one turnkey contract. Their understanding of Uzbekistan’s evolving GMP standards meant we were certified ahead of schedule and exporting to Kazakhstan within the first year.”
Mr. R
General Director
-
“Their IV solution line has been running with excellent reliability since commissioning. The technology transfer program was thorough — our operators were fully independent within weeks. IVEN is a trusted partner for Central Asian pharmaceutical projects.”
Dr. K
Chief Engineer
